Johnson & Johnson
NYSE: JNJ
$147.03
-$0.74 (-0.5%)
Closing Price on January 17, 2025
JNJ Articles
ThinkstockIn the second quarter of this year, U.S. corporate profits totalled $1.8 trillion after taxes. Massive corporate profit is not limited to the United States, although many of the world’s...
Published:
Last Updated:
ThinkstockJanssen Biotech announced that the U.S. Food and Drug Administration (FDA) approved Yondelis (trabectedin) for the treatment of patients with unresectable or metastatic liposarcoma (LPS) or...
Published:
Last Updated:
ThinkstockOctober 15, 2015: Markets opened higher on Thursday following a strong showing for stocks in both Asia and Europe. Biotech stocks continue to get new life, helping overcome some softness in...
Published:
Last Updated:
Johnson & Johnson reported mixed third-quarter 2015 results before markets opened Tuesday morning.
Published:
Johnson & Johnson is scheduled to report its third-quarter financial results before the markets open on Tuesday.
Published:
24/7 Wall St. has put together a preview of some of the Dow Jones Industrial Average companies that are reporting their quarterly results this week.
Published:
Monday's top analyst upgrades, downgrades and initiations include AutoZone, Discover Financial Services, IBM, Microsoft, Twitter, Viacom and Wynn Resorts.
Published:
Its stock has suffered, but it is possible that Achillion’s interim trial results may have put the company back on the right track.
Published:
thinkstockSeptember 3, 2015: Markets opened higher on Thursday after the European Central Bank president indicated that the ECB would continue quantitative easing program. Markets in China and Hong...
Published:
Last Updated:
thinkstockAugust 28, 2015: Markets opened lower on Friday, and except for a brief visit above the break-even line, the blue chips traded lower all day. Crude oil settled at $45.22, up more than 6% on...
Published:
Last Updated:
Led by Apple and Intel, the Dow 30 stocks have engineered a significant recovery since the opening bell rang Monday morning.
Published:
Last Updated:
In a new research report, the technical team at RBC highlight stocks and sectors that are working and are clearly safer than crowded momentum stocks.
Published:
Where will the most brilliant investor in the world put his money if the markets collapse? Perhaps into some of the safe harbor stocks he already holds.
Published:
Independent research firm Argus has maintained its Buy rating and its $85.00 price target on AbbVie.
Published:
Stockcharts.comLong-term investors always look for companies that show signs that they will be around for a while. Membership on the Dividend Aristocrats list gives indication of longevity. In order...
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.